Shine Investment Advisory Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$81K Hold
930
0.03% 223
2020
Q2
$81K Buy
930
+86
+10% +$7.42K 0.03% 222
2020
Q1
$70K Sell
844
-213
-20% -$19K 0.03% 226
2019
Q4
$100K Buy
1,057
+250
+31% +$22.4K 0.04% 212
2019
Q3
$70K Hold
807
0.03% 242
2019
Q2
$74K Sell
807
-114
-12% -$9.65K 0.03% 232
2019
Q1
$79K Sell
921
-474
-34% -$38.1K 0.04% 223
2018
Q4
$107K Sell
1,395
-147
-10% -$11.4K 0.05% 161
2018
Q3
$119K Buy
1,542
+28
+2% +$2.07K 0.06% 155
2018
Q2
$103K Buy
1,514
+491
+48% +$33.9K 0.05% 170
2018
Q1
$74K Buy
1,023
+195
+24% +$14.8K 0.04% 227
2017
Q4
$62K Hold
828
0.03% 257
2017
Q3
$64K Hold
828
0.03% 249
2017
Q2
$62K Buy
+828
New +$58.7K 0.03% 238

Other funds holding NVS

Shine Investment Advisory Services's NVS Position: Q3 2020 in Review

Shine Investment Advisory Services held its Novartis (NVS) position steady in Q3 2020 at 930 shares worth $81K. The position accounts for 0.03% of the portfolio, ranked #223.

Shine Investment Advisory Services first reported a position in NVS in Q2 2017 and has held it in 14 quarters since. The position peaked at $119K in Q3 2018. 1,119 funds tracked by Wall St. Rank hold NVS as of Q3 2020.

  • Shine Investment Advisory Services held 930 shares of Novartis worth $81K as of Q3 2020.
  • Shine Investment Advisory Services left its Novartis share count unchanged in Q3 2020.
  • Novartis made up 0.03% of Shine Investment Advisory Services's portfolio in Q3 2020, its #223 holding.
  • Shine Investment Advisory Services first reported a position in Novartis in Q2 2017 and has held it in 14 quarters since.
  • Shine Investment Advisory Services's Novartis position peaked at $119K in Q3 2018.
  • 1,119 funds tracked by Wall St. Rank held Novartis as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.